To further assess the tumor-forming ability of PCSK9, we established a liver transplantation model by orthotopically injecting Huh7 and PLC/PRF/5 cells transfected with shPCSK9#1 or a negative control (shNC) into the left hepatic lobe. This evidence concerns the gene PCSK9 and neoplasm.